Susan Baltz
Family · Amarillo, TXNPI 1992919484
Payments from drug & device makers
Across 75 payments — averaging $83.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$939
- GSK$799
- AstraZeneca$750
- Phathom Pharmaceuticals, Inc.$400
- Astellas Pharma US Inc$375
- Novo Nordisk$316
- plus $3K from 20 others
What the payments were for
- Food & beverage$6,213100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $939 |
| GSK | 8 | $799 |
| AstraZeneca | 7 | $750 |
| Phathom Pharmaceuticals, Inc. | 5 | $400 |
| Astellas Pharma US Inc | 3 | $375 |
| Novo Nordisk | 3 | $316 |
| Neurocrine Biosciences, Inc. | 5 | $309 |
| Bayer | 3 | $300 |
| Acadia Pharmaceuticals Inc | 6 | $269 |
| Avanir Pharmaceuticals, Inc. | 6 | $227 |
| Abbott | 2 | $186 |
| Amgen | 2 | $165 |
| Medtronic | 1 | $156 |
| Sanofi | 1 | $129 |
| Optinose US, Inc. | 2 | $127 |
| Madrigal Pharmaceuticals | 1 | $125 |
| Johnson & Johnson | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Kyowa Kirin, Inc. | 1 | $110 |
| Access Vascular Inc | 1 | $87 |
| Biohaven Pharmaceuticals, Inc. | 1 | $68 |
| Boehringer Ingelheim | 1 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $34 |
| Biogen | 1 | $23 |
| Urovant Sciences Inc | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,230 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $12,741 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $2,349 |
| Gabapentin | 51 | $1,285 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $877 |
| Potassium Chloride | 74 | $738 |
| Omeprazole | 39 | $661 |
| Tizanidine Hcl | 23 | $543 |
| Hydroxyzine Pamoate | 21 | $541 |
| Dicyclomine Hcl | 11 | $502 |
| Atorvastatin Calcium | 57 | $435 |
| Levothyroxine Sodium | 44 | $432 |
| Baclofen | 15 | $391 |
| Donepezil Hcl | 36 | $361 |
| Ropinirole Hcl | 14 | $281 |
| Escitalopram Oxalate | 24 | $280 |
Paid to pharmacies, not to this prescriber.
Other family in Amarillo
- Kyla BeedyAmarillo$54K
- Tiffany RandleAmarillo$50K
- Cory PickettAmarillo$34K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.